What is Stifel's price target for BPMC?

Stifel's latest stated price target for Blueprint Medicines Corporation (BPMC) is $105, from its action on Mar 4, 2022.

What is Stifel's rating on BPMC?

Stifel rates BPMC Buy, a bullish rating, as of Mar 4, 2022.

When did Stifel last change its view on BPMC?

On Mar 4, 2022, Stifel raises its price target to $105 from $100, keeps Buy.

Stifel BPMC price target and rating history

Blueprint Medicines Corporation (BPMC) · Health Care

Stifel rates Blueprint Medicines Corporation (BPMC) Buy with a $105 price target, as of its latest action on Mar 4, 2022. It has published 3 rating actions on BPMC since September 2021, including 1 upgrade and 0 downgrades.

Current rating: Buy
Price target: $105
Median target, all firms: Too few
Actions on BPMC: 3

Stifel price target on BPMC

Stifel price target on BPMC, each point a stated target, September 2021 to March 2022.

Every Stifel rating on BPMC

Mar 4, 2022
ReiterateStifel raises its price target to $105 from $100, keeps Buy
Jan 25, 2022
UpgradeStifel upgrades to Buy from Hold, price target $120 to $95
Sep 30, 2021
ResumeStifel resumes coverage at Hold, price target $105

Questions about Stifel and BPMC

What is Stifel's price target for BPMC?: Stifel's latest stated price target for Blueprint Medicines Corporation (BPMC) is $105, from its action on Mar 4, 2022.
What is Stifel's rating on BPMC?: Stifel rates BPMC Buy, a bullish rating, as of Mar 4, 2022.
When did Stifel last change its view on BPMC?: On Mar 4, 2022, Stifel raises its price target to $105 from $100, keeps Buy.

More BPMC rating histories

All Stifel ratings BPMC news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.